For uncontrolled diabetes mellitus patients, SGLT-2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists are regarded as first-line add-on medications to maintain glycemic control. The gene discussed is GLP1R; the disease is diabetes mellitus.